Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors.
暂无分享,去创建一个
V. Calvez | F. Ceccherini‐Silberstein | C. Katlama | A. Antinori | A. Monforte | C. Perno | S. Alcaro | S. Bono | G. Costa | A. Artese | V. Svicher | L. Fabeni | R. D'arrigo | A. Marcelin | I. Malet | S. Dimonte | Giosuè Costa